CBFP
PFE icon

Cedar Brook Financial Partners’s Pfizer PFE Stock Holding History

Cedar Brook Financial Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,958
Closed -$387K – 287
2024
Q1 		$387K Sell
13,958
-710
-5% -$19.7K 0.08% 259
2023
Q4 		$417K Sell
14,668
-1,453
-9% -$43.9K 0.09% 221
2023
Q3 		$535K Sell
16,121
-3,772
-19% -$133K 0.14% 161
2023
Q2 		$730K Sell
19,893
-2,015
-9% -$78.4K 0.17% 132
2023
Q1 		$894K Buy
21,908
+1,431
+7% +$61.8K 0.23% 112
2022
Q4 		$1.05M Buy
20,477
+1,331
+7% +$63.8K 0.3% 91
2022
Q3 		$838K Buy
19,146
+676
+4% +$32.8K 0.27% 97
2022
Q2 		$968K Sell
18,470
-888
-5% -$45.3K 0.3% 88
2022
Q1 		$1M Buy
19,358
+661
+4% +$34.3K 0.26% 93
2021
Q4 		$1.1M Buy
18,697
+5,268
+39% +$261K 0.28% 86
2021
Q3 		$578K Sell
13,429
-1,645
-11% -$72.9K 0.17% 147
2021
Q2 		$590K Buy
15,074
+2,738
+22% +$106K 0.17% 149
2021
Q1 		$447K Sell
12,336
-5,072
-29% -$180K 0.15% 157
2020
Q4 		$641K Buy
17,408
+826
+5% +$30.3K 0.23% 113
2020
Q3 		$577K Buy
16,582
+3,048
+23% +$107K 0.23% 122
2020
Q2 		$420K Buy
13,534
+206
+2% +$7K 0.19% 147
2020
Q1 		$413K Buy
13,328
+2,695
+25% +$91.8K 0.23% 129
2019
Q4 		$395K Sell
10,633
-2,499
-19% -$89K 0.17% 163
2019
Q3 		$448K Sell
13,132
-1,812
-12% -$65.9K 0.2% 154
2019
Q2 		$614K Buy
14,944
+358
+2% +$14.2K 0.28% 115
2019
Q1 		$588K Buy
14,586
+319
+2% +$12.8K 0.29% 108
2018
Q4 		$591K Buy
+14,267
New +$592K 0.36% 88

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cedar Brook Financial Partners's PFE Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Pfizer (PFE) in Q2 2024, closing a stake of 13,958 shares — an estimated $387K sold.

Cedar Brook Financial Partners first reported a position in PFE in Q4 2018 and held it in 22 quarters. The position peaked at $1.1M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 13,958 Pfizer shares in Q2 2024, an estimated $387K.
  • Cedar Brook Financial Partners first reported a position in Pfizer in Q4 2018 and held it in 22 quarters.
  • Cedar Brook Financial Partners's Pfizer position peaked at $1.1M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.